Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Launched by MARSHALL UNIVERSITY · Feb 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how three different medications—labetalol, atenolol, and nifedipine—affect blood flow and heart function in women during the early stages of pregnancy, specifically before 15 weeks. The goal is to understand how these medications can help manage high blood pressure that can occur in pregnancy, which is important for both the mother and baby’s health.

To participate in the trial, women aged 18 to 45 who speak English and are experiencing high blood pressure at the Maternal Hypertension Center at Cabell Huntington Hospital can join. Participants will take medication based on their individual health needs and will return for follow-up tests to measure how their body responds to the treatment. This research is vital as it could lead to better management of pregnancy-related high blood pressure, ensuring healthier outcomes for mothers and their babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
• • English speaking
• • 18-45 years old.
• • Willing to provide informed consent
• • Gestational age prior to 15 weeks gestation
• Exclusion Criteria:
• • Non-English speaking patients, patients
• • \<18 years old or \>45 years old
• • Not willing or able to provide consent
• • Gestational age \>15 weeks